<p>Jennifer Michaelson, Chief Scientific Officer, reported a disposal of common shares of Cullinan Therapeutics Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cullinan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-328909), on December 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CGEM

<p>Jennifer Michaelson, Chief Scientific Officer of Cullinan Therapeutics Inc., reported the disposal of common shares. The details are available in a filing on the U.S. SEC's EDGAR system. This information is for informational purposes and not financial advice.</p>

Cullinan Therapeutics Chief Scientific Officer Jennifer Michaelson Reports Disposal of Common Shares